Literature DB >> 19451293

A balancing act: efflux/influx in mycobacterial drug resistance.

G E Louw1, R M Warren, N C Gey van Pittius, C R E McEvoy, P D Van Helden, T C Victor.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19451293      PMCID： PMC2715638          DOI： 10.1128/AAC.01577-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  130 in total

Review 1.  Efflux pumps: their role in antibacterial drug discovery.

Authors:  O Lomovskaya; W J Watkins
Journal:  Curr Med Chem       Date:  2001-12       Impact factor: 4.530

2.  The rapid development of fluoroquinolone resistance in M. tuberculosis.

Authors:  Amy Sarah Ginsburg; Samuel C Woolwine; Nancy Hooper; William H Benjamin; William R Bishai; Susan E Dorman; Timothy R Sterling
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

3.  Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis.

Authors:  H Taniguchi; H Aramaki; Y Nikaido; Y Mizuguchi; M Nakamura; T Koga; S Yoshida
Journal:  FEMS Microbiol Lett       Date:  1996-10-15       Impact factor: 2.742

4.  New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains.

Authors:  M Ristow; M Möhlig; M Rifai; H Schatz; K Feldmann; A Pfeiffer
Journal:  Lancet       Date:  1995-08-19       Impact factor: 79.321

5.  B-subunit of phosphate-specific transporter from Mycobacterium tuberculosis is a thermostable ATPase.

Authors:  J Sarin; S Aggarwal; R Chaba; G C Varshney; P K Chakraborti
Journal:  J Biol Chem       Date:  2001-09-20       Impact factor: 5.157

6.  Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.

Authors:  L J Piddock; K J Williams; V Ricci
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

7.  Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.

Authors:  Courtney E Maus; Bonnie B Plikaytis; Thomas M Shinnick
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 8.  Promising therapy of XDR-TB/MDR-TB with thioridazine an inhibitor of bacterial efflux pumps.

Authors:  L Amaral; M Martins; M Viveiros; J Molnar; J E Kristiansen
Journal:  Curr Drug Targets       Date:  2008-09       Impact factor: 3.465

Review 9.  The envelope of mycobacteria.

Authors:  P J Brennan; H Nikaido
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

10.  The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis.

Authors:  Edda De Rossi; Patrizio Arrigo; Marco Bellinzoni; Pedro A E Silva; Carlos Martín; José A Aínsa; Paola Guglierame; Giovanna Riccardi
Journal:  Mol Med       Date:  2002-11       Impact factor: 6.354
View more
  83 in total

1.  Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery.

Authors:  Meenakshi Balganesh; Sanjana Kuruppath; Nimi Marcel; Sreevalli Sharma; Anju Nair; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.

Authors:  Gail E Louw; Robin M Warren; Nicolaas C Gey van Pittius; Rosalba Leon; Adelina Jimenez; Rogelio Hernandez-Pando; Christopher R E McEvoy; Melanie Grobbelaar; Megan Murray; Paul D van Helden; Thomas C Victor
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

3.  Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease.

Authors:  Kirsten Famulla; Peter Sass; Imran Malik; Tatos Akopian; Olga Kandror; Marina Alber; Berthold Hinzen; Helga Ruebsamen-Schaeff; Rainer Kalscheuer; Alfred L Goldberg; Heike Brötz-Oesterhelt
Journal:  Mol Microbiol       Date:  2016-04-01       Impact factor: 3.501

Review 4.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

5.  Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

Authors:  Katherine A Rawls; P Therese Lang; Jun Takeuchi; Shinichi Imamura; Tyler D Baguley; Christoph Grundner; Tom Alber; Jonathan A Ellman
Journal:  Bioorg Med Chem Lett       Date:  2009-10-25       Impact factor: 2.823

Review 6.  Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.

Authors:  Claudio U Köser; Silke Feuerriegel; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

7.  Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.

Authors:  Analise Z Reeves; Patricia J Campbell; Razvan Sultana; Seidu Malik; Megan Murray; Bonnie B Plikaytis; Thomas M Shinnick; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

8.  Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.

Authors:  Nicholas D Walter; Gregory M Dolganov; Benjamin J Garcia; William Worodria; Alfred Andama; Emmanuel Musisi; Irene Ayakaka; Tran T Van; Martin I Voskuil; Bouke C de Jong; Rebecca M Davidson; Tasha E Fingerlin; Katerina Kechris; Claire Palmer; Payam Nahid; Charles L Daley; Mark Geraci; Laurence Huang; Adithya Cattamanchi; Michael Strong; Gary K Schoolnik; John Lucian Davis
Journal:  J Infect Dis       Date:  2015-03-11       Impact factor: 5.226

9.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  The Mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic molecules.

Authors:  Olga Danilchanka; David Pires; Elsa Anes; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.